CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 2,300 shares, a drop of 66.2% from the May 15th total of 6,800 shares. Currently, 0.0% of the company’s stock are sold short. Based on an […]
CollPlant Biotechnologies (NASDAQ:CLGN – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, May 29th. Analysts expect the company to announce earnings of ($0.35) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. […]
Bone Biologics (NASDAQ:BBLG – Get Free Report) and CollPlant Biotechnologies (NASDAQ:CLGN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Analyst Recommendations This is a breakdown of […]
Bone Biologics (NASDAQ:BBLG – Get Free Report) and CollPlant Biotechnologies (NASDAQ:CLGN – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Analyst Ratings This is a summary of […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for CollPlant Biotechnologies in a note issued to investors on Friday, April 5th. HC Wainwright analyst S. Ramakanth anticipates that the company will post earnings of ($0.36) per share for the quarter. HC Wainwright currently […]